Adaptin Bio (APTN) Accounts Payables (2022 - 2026)
Adaptin Bio (APTN) posted Accounts Payables of $1.4 million for Q1 2026, down 9.31% sequentially from $1.5 million in Q4 2025, and up 319.29% YoY from $327057.0 in Q1 2025.
Adaptin Bio (APTN) Accounts Payables (2022 - 2026) Analysis & Trends
Adaptin Bio has reported Accounts Payables for 5 years, with the latest figure at $1.4 million in Q1 2026.
- Quarterly Accounts Payables rose 319.29% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 319.29% YoY) and the FY2025 annual result came in at $1.5 million, up 11.09% from the prior year.
- Accounts Payables declined to $1.4 million in Q1 2026 per APTN's latest filing, from $1.5 million in the prior quarter.
- Over five years, Accounts Payables peaked at $1.5 million in Q4 2025 and troughed at $58.0 in Q4 2023.
- A 5-year average of $564688.8 and a median of $190091.5 in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables plunged 99.54% in 2023, then surged 2346591.38% in 2024.
- Over 5 years, Accounts Payables stood at $12500.0 in 2022, then slumped by 99.54% to $58.0 in 2023, then soared by 2346591.38% to $1.4 million in 2024, then climbed by 11.09% to $1.5 million in 2025, then slipped by 9.31% to $1.4 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $1.4 million, $1.5 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 666,570.00 |
| Mar 31, 2025 | 327,057.00 |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 53,126.00 |
| Jun 30, 2024 | 52,917.00 |
| Mar 31, 2024 | 52,982.00 |
| Dec 31, 2023 | 58.00 |
| Sep 30, 2023 | 28,500.00 |
| Dec 31, 2022 | 12,500.00 |